Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.9600 (-0.27%) ($12.8300 - $13.3600) on Thu. Jun. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 73 | Latest Price | $12.9600(-0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.6% a day on average for past five trading days. | Weekly Trend | FOLD advances 6.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(62%) IBB(57%) IWO(42%) IWM(41%) IWN(39%) | Factors Impacting FOLD price | FOLD will decline at least -1.135% in a week (0% probabilities). TBT(-32%) UUP(-15%) VXX(-11%) BNDX(-2%) VIXM(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
5 Day Moving Average | $12.88(0.62%) | 10 Day Moving Average | $12.55(3.27%) | 20 Day Moving Average | $12.02(7.82%) | To recent high | -0.3% | To recent low | 20.6% | Market Cap | $3.347b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |